Name:
Dr Mireia Crispin
Job Title:
Group Leader, Early Cancer Institute
Associate Professor, Department of Oncology
Organisation / Company:
University of Cambridge
Biography:
Dr Mireia Crispin is an Associate Professor in the Department of Oncology of the University of Cambridge and Group Leader at the Early Cancer Institute. Her research group focuses on the development of radiogenomic data integration models to understand and predict the evolution of hard-to-treat cancers. She co-leads the Women’s Cancers Programme at the CRUK Cambridge Centre, and the Mark Foundation Institute for Integrated Cancer Medicine. She is also co-founder and Chief Digital Officer of 52 North Health, an award-winning biotech start-up developing affordable at-home tests for cancer patients. Dr Crispin worked previously at Memorial Sloan Kettering Cancer Center in New York, and was the Director of the Healthcare Innovation programme of the Center for the Governance of Change at IE University (Madrid, Spain), focusing on policy challenges for the integration of AI and digital health in European healthcare. She holds a PhD in Particle Physics (University of Oxford, 2015). She is an author in over 400 publications and has received numerous national and international awards, most recently finalist of the Cancer Research Horizons Early-Career (2022) and Woman Entrepreneur of the Year (2025) awards.